BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

699 related articles for article (PubMed ID: 9723694)

  • 21. Simultaneous targeting of CD3 on T cells and CD40 on B or dendritic cells augments the antitumor reactivity of tumor-primed lymph node cells.
    Li Q; Grover AC; Donald EJ; Carr A; Yu J; Whitfield J; Nelson M; Takeshita N; Chang AE
    J Immunol; 2005 Aug; 175(3):1424-32. PubMed ID: 16034078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD40 ligand-positive CD8+ T cell clones allow B cell growth and differentiation.
    Hermann P; Van-Kooten C; Gaillard C; Banchereau J; Blanchard D
    Eur J Immunol; 1995 Oct; 25(10):2972-7. PubMed ID: 7589100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions.
    Van den Eertwegh AJ; Noelle RJ; Roy M; Shepherd DM; Aruffo A; Ledbetter JA; Boersma WJ; Claassen E
    J Exp Med; 1993 Nov; 178(5):1555-65. PubMed ID: 7693849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of cytoplasmic, surface and soluble forms of CD40 ligand in mouse B cells.
    Wykes M; Poudrier J; Lindstedt R; Gray D
    Eur J Immunol; 1998 Feb; 28(2):548-59. PubMed ID: 9521065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation.
    Dahlén E; Hedlund G; Dawe K
    J Immunol; 2000 Mar; 164(5):2444-56. PubMed ID: 10679081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of costimulation prevents infection-induced immunopathology in interleukin-10-deficient mice.
    Villegas EN; Wille U; Craig L; Linsley PS; Rennick DM; Peach R; Hunter CA
    Infect Immun; 2000 May; 68(5):2837-44. PubMed ID: 10768980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD40-CD40L interactions provide "third-party" costimulation for T cell response against B7-1-transfected human breast tumor cells.
    Pericle F; Epling-Burnette PK; Podack ER; Wei S; Djeu JY
    J Leukoc Biol; 1997 Feb; 61(2):201-8. PubMed ID: 9021926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of CD40 ligand in costimulation and T-cell activation.
    Grewal IS; Flavell RA
    Immunol Rev; 1996 Oct; 153():85-106. PubMed ID: 9010720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of protective immunity against an immunogenic carcinoma requires CD40/CD40L and B7/CD28 interactions but not CD4(+) T cells.
    Eck SC; Turka LA
    Cancer Immunol Immunother; 1999 Sep; 48(6):336-41. PubMed ID: 10473809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B7/CD28-dependent and -independent induction of CD40 ligand expression.
    Ding L; Green JM; Thompson CB; Shevach EM
    J Immunol; 1995 Dec; 155(11):5124-32. PubMed ID: 7594521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis.
    Blair PJ; Riley JL; Harlan DM; Abe R; Tadaki DK; Hoffmann SC; White L; Francomano T; Perfetto SJ; Kirk AD; June CH
    J Exp Med; 2000 Feb; 191(4):651-60. PubMed ID: 10684857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B cells from CBA/N mice do not proliferate following ligation of CD40.
    Hasbold J; Klaus GG
    Eur J Immunol; 1994 Jan; 24(1):152-7. PubMed ID: 7517360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of costimulatory molecules in chronic inflammatory periodontal disease tissue.
    Orima K; Yamazaki K; Aoyagi T; Hara K
    Clin Exp Immunol; 1999 Jan; 115(1):153-60. PubMed ID: 9933436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40.
    Yang Y; Wilson JM
    Science; 1996 Sep; 273(5283):1862-4. PubMed ID: 8791591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-linking of the CD40 ligand on human CD4+ T lymphocytes generates a costimulatory signal that up-regulates IL-4 synthesis.
    Blotta MH; Marshall JD; DeKruyff RH; Umetsu DT
    J Immunol; 1996 May; 156(9):3133-40. PubMed ID: 8617933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71).
    Chirmule N; McCloskey TW; Hu R; Kalyanaraman VS; Pahwa S
    J Immunol; 1995 Jul; 155(2):917-24. PubMed ID: 7541827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increase of intracellular calcium is the essential signal for the expression of CD40 ligand.
    Nüsslein HG; Frosch KH; Woith W; Lane P; Kalden JR; Manger B
    Eur J Immunol; 1996 Apr; 26(4):846-50. PubMed ID: 8625977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro hematopoiesis produces a distinct class of immature dendritic cells from spleen progenitors with limited T cell stimulation capacity.
    Quah B; Ni K; O'Neill HC
    Int Immunol; 2004 Apr; 16(4):567-77. PubMed ID: 15039387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The roles of CD28 and CD40 ligand in T cell activation and tolerance.
    Howland KC; Ausubel LJ; London CA; Abbas AK
    J Immunol; 2000 May; 164(9):4465-70. PubMed ID: 10779746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B cell-mediated down-regulation of IFN-gamma and IL-12 production induced during anti-tumor immune responses in the tumor-bearing state.
    Wijesuriya R; Maruo S; Zou JP; Ogawa M; Umehara K; Yamashita M; Ono S; Fujiwara H; Hamaoka T
    Int Immunol; 1998 Aug; 10(8):1057-65. PubMed ID: 9723691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.